Levy JH

Idioma: Ingles.
Referencias bibliográficas: 13
Paginas: 52-53
Archivo PDF: 54.95 Kb.

FRAGMENTO

No tiene resumen

REFERENCIAS (EN ESTE ARTÍCULO)

1. Alderman EL, Levy JH, Rich J, et al. International multi-center aprotinin graft patency experience (IMAGE). J Thorac Cardiovasc Surg 1998;116:716-730.

2. Despotis GJ, Filos K, Gravlee G, Levy J. Anticoagulation monitoring during cardiac surgery: a survey of current practice and review of current and emerging techniques. Anesthesiology 1999;91:1122-1151.

3. Despotis GJ. Skubas NJ. Goodnough LT. Optimal management of bleeding and transfusion in patients undergoing cardiac surgery. Seminars in Thoracic & Cardiovascular Surgery. 1999;11(2):84-104.

4. Hedner U. Recombinant coagulation factor VIIa: From the concept to clinical application in hemophilia treatment in 2000. Semin Thromb Hemost 2000;26:363.

5. Levy JH, Goodnough LT, Grelich P, et al. A room temperature stable hemoglobin (HBOC-201) eliminates allogeneic red blood cell transfusion in postoperative cardiac surgery patients. J Thorac Cardiovasc Surg 2002;124:35-42.

6. Levy JH, Pifarre R, Schaff H, et al. A multicenter, placebo-controlled, double-blind trial of aprotinin to reduce blood loss and the requirement of donor blood transfusion in patients undergoing repeat CABG. Circulation 1995;92:2236-2244.

7. Levy JH. Hemostatic agents and their safety. J Cardioth Anesth 1999;13(S1):6-11.

8. Levy JH. Novel intravenous antithrombins. American Heart Journal (Suppl), Am Heart J 2001;141:1043-1047.

9. Levy JH. Pharmacologic preservation of the hemostatic system during cardiac surgery. Ann Thorac Surg 2001;72:S1814-1820.

10. Levy JH: Novel pharmacologic approaches to reduce bleeding. Can J Anaesth 2003;50(6 Suppl):S26-30.

11. Miller BE, Tosone SR, Tam VKH, et al. Hematologic and economic impact of aprotinin in reop pediatric cardiac surgery. Ann Thorac Surg 1998;66:535-540.

12. Mojcik C, Levy JH. Systemic inflammatory response syndrome and anti-inflammatory strategies. Ann Thorac Surg 2001;71:745-754.

13. Tanaka KA, Waly A, Cooper WA, Levy JH. Treatment of excessive bleeding in Jehovah’s Witness patients after cardiac surgery with recombinant activated Factor VII (NovoSeven®). Anesthesiology 2003;98:1513-5.